AdvisorShares Investments LLC Buys 15,948 Shares of Clearmind Medicine Inc. (NASDAQ:CMND)

AdvisorShares Investments LLC raised its stake in Clearmind Medicine Inc. (NASDAQ:CMND) by 14.2% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 128,641 shares of the company’s stock after acquiring an additional 15,948 shares during the period. AdvisorShares Investments LLC owned approximately 7.60% of Clearmind Medicine worth $214,000 as of its most recent SEC filing.

Separately, Cornerstone Wealth Group LLC bought a new position in Clearmind Medicine in the 2nd quarter worth about $34,000. Institutional investors and hedge funds own 96.05% of the company’s stock.

Clearmind Medicine Stock Performance

NASDAQ:CMND opened at $1.30 on Thursday. The firm has a 50-day simple moving average of $1.45 and a two-hundred day simple moving average of $1.33. Clearmind Medicine Inc. has a fifty-two week low of $0.92 and a fifty-two week high of $12.60.

Clearmind Medicine (NASDAQ:CMND) last announced its quarterly earnings data on Thursday, June 13th. The company reported ($0.28) earnings per share for the quarter.

Clearmind Medicine Company Profile

Clearmind Medicine Inc, a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors.